OOIR: Observatory of International Research

Papers

(The H4-Index of Translational Oncology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunities	1513
Comment on: AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario	131
Hypoxia induced cell dormancy of salivary adenoid cystic carcinoma through miR-922/DEC2 axis	109
Which evaluation criteria of the short-term efficacy can better reflect the long-term outcomes for patients with nasopharyngeal carcinoma?	98
Analysis of patient reported outcomes included in the registrational clinical trials of nivolumab for advanced non-small cell lung cancer	96
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma	80
Role of 3-mercaptopyruvate sulfurtransferase in cancer: Molecular mechanisms and therapeutic perspectives	77
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma	73
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors	69
Lung cancer and oncolytic virotherapy——enemy's enemy	59
Extracellular vesicle-orchestrated crosstalk between cancer-associated fibroblasts and tumors	55
Identification of metastasis-associated exoDEPs in colorectal cancer using label-free proteomics	53
circ-ZEB1 regulates epithelial-mesenchymal transition and chemotherapy resistance of colorectal cancer through acting on miR-200c-5p	51
Application of predictive model based on CT radiomics and machine learning in diagnosis for occult locally advanced esophageal squamous cell carcinoma before treatment: A two-center study	49
A novel multifunctional anti-PD-L1-CD16a-IL15 induces potent cancer cell killing in PD-L1-positive tumour cells	48
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells	45
The double face of cold in cancer	45
The roles of Linc-ROR in the regulation of cancer stem cells	44
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection	44
Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition	42
MAGI2-AS3 hypermethylated in promoter region promotes migration and invasion of head and neck squamous cell carcinoma via miRNA-31-5p/AR axis	42
Hypericin mediated photodynamic therapy induces ferroptosis via inhibiting the AKT/mTORC1/GPX4 axis in cholangiocarcinoma	42
Type of chemotherapy has substantial effects on the immune system in ovarian cancer	41
Corrigendum to “Comprehensive expression, prognostic and validation analysis of necroptosis-related lncRNAs in esophageal cancer” [Transl Oncol. 2024 Aug;46:101983.]	41
Single-treatment tumor ablation with photodynamic liposomal irinotecan sucrosulfate	41

AFP shields hepatocellular carcinoma from macrophage phagocytosis by regulating HuR-mediated CD47 translocation in cellular membrane	41
ERβ-regulated circATP2B1/miR-204–3p/TWIST1 positive feedback loop facilitates epithelial to mesenchymal transition in clear cell renal cell carcinoma	40
Universal CAR cell therapy: Challenges and expanding applications	40
Inhibition of hERG by ESEE suppresses the progression of colorectal cancer	40
High expression of PAX8-AS1 correlates with poor prognosis and response to fluorouracil-based chemotherapy in stage II colon cancer	38
Prognostic significance of combined PCPE-1 and α-fetoprotein for hepatocellular carcinoma	37
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients	35
ISO-upregulated BECN1 specifically promotes LC3B-dependent autophagy and anticancer activity in invasive bladder cancer	35
CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer	34
Improving differential diagnosis of pulmonary large cell neuroendocrine carcinoma and small cell lung cancer via a transcriptomic, biological pathway-based machine learning model	34
68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors	34
Integrated multi-omics demonstrates enhanced antitumor efficacy of donafenib combined with FADS2 inhibition in hepatocellular carcinoma	34